As the world continues to face the public health, social, and economic unravelling due to the COVID-19 crisis, it should be clear that, The World Bank Group is helping developing countries purchase and distribute vaccines and strengthen health systems through a $12 billion vaccine financing facility, which complements the $6 billion Global COVID-19 Strategic Preparedness and Response Program in the health sector approved in April 2020 and that now covers more than 110 countries.
Deadline: 10-Jul-2017 at 11:59:59 PM (Eastern Time – Washington D.C.)
The Objective: The main objective of this assignment is to introduce regulatory reforms and also build the Veterinary Drugs and Feed Administration and Control Authorities capacity to enable it execute its role more efficiently.
Scope of Overall Work: The scope of overall work involves but is not limited to:
a) Capacity-building of VDFACA and its technical staff in the relevant areas of regulatory processes
b) Recommending and assisting VDFACA to implement streamlined registration and licensing procedures for the veterinary drugs, vaccines and animal compound feeds through, simplification, rationalization, and where possible and desirable, automation. This is in relation to procedures that are VDFACA s responsibility
c) Assisting VDFACA to increase the consistency and predictability of registration and licensing procedures
d) Strengthen VDFACAs capacity to conduct inspections on drug consignments at ports of entry, wholesale and retail outlets
e) Support VDFACA to increase its capacity for pharmacovigilance (market surveillance)
f) Support VDFACAs and or MoLFs capacity to address anti-microbial resistance and animal food residues
g) Upgrading of VDFACA laboratory staffs capacity to conduct tests on drug samples
Deadline: 01-Oct-2015 at 11:59:59 PM (Eastern Time – Washington D.C.)
The World Bank is managing a trust fund for medicines regulatory harmonization (MRH) and is currently working with three Africa sub-regions (EAC, ECOWAS, SADC) on regional harmonization projects with a focus on generic drugs in partnership with WHO and NEPAD. This consultancy will focus on adding vaccines to this work program, specifically their inclusion in the regional road map for regulatory harmonization.